Walgreens builds specialty pharmacy community
Specialty medications have emerged as one of the fastest-growing segments of the overall pharmacy field.
Specialty medications have emerged as one of the fastest-growing segments of the overall pharmacy field.
Patient communication network PatientsLikeMe has broadened the scope of patient-generated information it offers through Walgreens.com. PatientsLikeMe said the new information highlights why patients use specific prescription drugs and how effective they think these medications are.
Publix Super Markets Inc. plans to implement a subset of VUCA Health’s MedsOnCue medication video library to improve education and medication adherence for specialty pharmacy patients.
Ascensia Diabetes Care has gained Food and Drug Administration 510(k) clearance for its Contour Next One blood glucose monitoring system. Ascensia said the approval marks a key step in making the Contour Next One available to Americans with diabetes.
Ateb Inc. has teamed up with Improved Patient Outcomes Inc. to provide population health management solutions aimed at improving medication adherence via patient behavioral changes.
If Obamacare is repealed, what will replace it? That is the question in the aftermath of the election of Donald Trump as president. Trump has vowed to “repeal and replace” the Affordable Care Act as his first act in office.
CutisPharma has opened a new research-and-development center in Woburn, Mass., to house the specialty pharmaceutical company’s expanding R&D team.
Walgreens has entered an agreement to become the retail pharmacy provider for northeastern Florida health system Baptist Health. Plans call for Baptist Health’s retail pharmacy operations to open under Walgreens’ ownership at Baptist Medical Center Jacksonville in early January.
Ralphs Grocery Co. this week began offering free blood glucose tests to help customers assess their risk for diabetes. The Los Angeles-area supermarket chain, part of The Kroger Co., is providing the glucose tests at its 80 in-store pharmacies through Nov. 20.
Taking medication efficacy and safety to an individual level, Fruth Pharmacy plans to offer the Rxight pharmacogenetics program from MD Labs.
Teva Pharmaceutical Industries Ltd. has expanded its antihypertensive portfolio with the rollout of two new generic products in the United States.
John Fegan has retired as vice president of pharmacy at Southeastern Grocers LLC. The food and drug retailer, the parent company of supermarket chains BI-LO, Harveys and Winn-Dixie, operates more than 500 pharmacies. Fegan joined Winn-Dixie as vice president of pharmacy in June 2008.
CVS Caremark has received health call center, pharmacy benefit management and drug therapy management accreditations from health standards body URAC.
Terica Gatewood left a retail pharmacy to work at Genoa, a QoL Healthcare Company, because she wanted a more clinical setting. At the Genoa pharmacy here, inside Valeo Behavioral Health, she has found that environment and then some.
Camber Pharmaceuticals has released rosuvastatin tablets, a cholesterol-lowering medication. Camber said Monday that its product, a generic version of Crestor tablets from AstraZeneca Pharmaceuticals, comes in strengths of 5 mg, 10 mg, 20 mg and 40 mg.
Though the vast majority of specialty physicians know what biosimilars are, their knowledge about these emerging medications falls short, according to a survey by the Biosimilars Forum. Of 1,201 U.S. physicians polled, 76.